C. Leyrat

First name
C.
Last name
Leyrat
Baptiste, P. J., Wong, A. Y. S., Schultze, A., Cunnington, M., Mann, J. F. E., Clase, C., et al. (2022). Effects of ACE inhibitors and angiotensin receptor blockers: protocol for a UK cohort study using routinely collected electronic health records with validation against the ONTARGET trial. Bmj Open, 12, e051907. http://doi.org/10.1136/bmjopen-2021-051907
Crellin, E., Mansfield, K. E., Leyrat, C., Nitsch, D., Douglas, I. J., Root, A., et al. (2018). Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study. Bmj. http://doi.org/10.1136/bmj.k341
Bidulka, P., Fu, E. L., Leyrat, C., Kalogirou, F., McAllister, K. S. L., Kingdon, E. J., et al. (2020). Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care. BMC Med. http://doi.org/10.1186/s12916-020-01659-x
Greenhall, G. H. B., Mansfield, K. E., Nitsch, D., Iwagami, M., Leyrat, C., Johnston, R., et al. (2020). The effect of initiation of renin-angiotensin system inhibitors on haemoglobin: A national cohort study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14429